News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,844 Results
Type
Article (45015)
Company Profile (331)
Press Release (671498)
Section
Business (208375)
Career Advice (2027)
Deals (36013)
Drug Delivery (109)
Drug Development (84400)
Employer Resources (175)
FDA (16725)
Job Trends (15123)
News (353664)
Policy (33363)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (11)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (10)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2709)
Academic (1)
Accelerated approval (3)
Adcomms (27)
Allergies (84)
Alliances (50913)
ALS (88)
Alzheimer's disease (1409)
Antibody-drug conjugate (ADC) (127)
Approvals (16703)
Artificial intelligence (242)
Autoimmune disease (17)
Automation (14)
Bankruptcy (367)
Best Places to Work (11872)
BIOSECURE Act (21)
Biosimilars (107)
Biotechnology (239)
Bladder cancer (63)
Brain cancer (28)
Breast cancer (261)
Cancer (2070)
Cardiovascular disease (164)
Career advice (1691)
Career pathing (29)
CAR-T (160)
Cell therapy (445)
Cervical cancer (18)
Clinical research (68165)
Collaboration (814)
Compensation (458)
Complete response letters (26)
COVID-19 (2679)
CRISPR (41)
C-suite (215)
Cystic fibrosis (104)
Data (1927)
Decentralized trials (2)
Denatured (21)
Depression (43)
Diabetes (255)
Diagnostics (6468)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (115)
Drug pricing (105)
Drug shortages (28)
Duchenne muscular dystrophy (90)
Earnings (87143)
Editorial (36)
Employer branding (21)
Employer resources (149)
Events (114927)
Executive appointments (643)
FDA (17836)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (714)
Gene editing (105)
Generative AI (20)
Gene therapy (315)
GLP-1 (750)
Government (4507)
Grass and pollen (4)
Guidances (48)
Healthcare (19369)
Huntington's disease (23)
IgA nephropathy (21)
Immunology and inflammation (116)
Indications (27)
Infectious disease (2811)
Inflammatory bowel disease (139)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (85)
Interviews (313)
IPO (16756)
IRA (42)
Job creations (3696)
Job search strategy (1437)
Kidney cancer (10)
Labor market (34)
Layoffs (484)
Leadership (16)
Legal (8016)
Liver cancer (73)
Lung cancer (305)
Lymphoma (134)
Machine learning (2)
Management (59)
Manufacturing (282)
MASH (64)
Medical device (13647)
Medtech (13652)
Mergers & acquisitions (19729)
Metabolic disorders (674)
Multiple sclerosis (69)
NASH (18)
Neurodegenerative disease (91)
Neuropsychiatric disorders (29)
Neuroscience (1905)
NextGen: Class of 2025 (6744)
Non-profit (4591)
Northern California (2421)
Now hiring (37)
Obesity (367)
Opinion (219)
Ovarian cancer (74)
Pain (83)
Pancreatic cancer (77)
Parkinson's disease (138)
Partnered (18)
Patents (208)
Patient recruitment (96)
Peanut (48)
People (58274)
Pharmaceutical (76)
Pharmacy benefit managers (18)
Phase I (21297)
Phase II (29972)
Phase III (22366)
Pipeline (993)
Podcasts (76)
Policy (117)
Postmarket research (2730)
Preclinical (9044)
Press Release (69)
Prostate cancer (95)
Psychedelics (38)
Radiopharmaceuticals (260)
Rare diseases (386)
Real estate (6017)
Recruiting (67)
Regulatory (22834)
Reports (46)
Research institute (2445)
Resumes & cover letters (352)
Rett syndrome (3)
RNA editing (2)
RSV (39)
Schizophrenia (69)
Series A (127)
Series B (81)
Service/supplier (12)
Sickle cell disease (54)
Southern California (2084)
Special edition (17)
Spinal muscular atrophy (156)
Sponsored (29)
Startups (3722)
State (2)
Stomach cancer (15)
Supply chain (60)
The Weekly (52)
United States (21410)
Vaccines (691)
Venture capitalists (37)
Webinars (12)
Weight loss (260)
Women's health (35)
Worklife (16)
Date
Today (121)
Last 7 days (584)
Last 30 days (2785)
Last 365 days (34681)
2025 (7909)
2024 (36416)
2023 (41153)
2022 (52435)
2021 (56957)
2020 (55227)
2019 (47786)
2018 (36075)
2017 (33187)
2016 (32633)
2015 (38663)
2014 (32336)
2013 (27383)
2012 (29513)
2011 (30202)
2010 (28405)
Location
Africa (750)
Alabama (49)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (39294)
Australia (6516)
California (5553)
Canada (1867)
China (490)
Colorado (251)
Connecticut (264)
Delaware (125)
Europe (86627)
Florida (825)
Georgia (198)
Idaho (58)
Illinois (505)
India (24)
Indiana (294)
Iowa (9)
Japan (141)
Kansas (103)
Kentucky (24)
Louisiana (7)
Maine (60)
Maryland (842)
Massachusetts (4242)
Michigan (209)
Minnesota (372)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (25)
Nevada (56)
New Hampshire (67)
New Jersey (1576)
New Mexico (30)
New York (1592)
North Carolina (980)
North Dakota (8)
Northern California (2421)
Ohio (193)
Oklahoma (15)
Oregon (36)
Pennsylvania (1260)
Puerto Rico (9)
Rhode Island (26)
South America (1126)
South Carolina (18)
South Dakota (1)
Southern California (2084)
Tennessee (94)
Texas (827)
Utah (167)
Virginia (128)
Washington D.C. (60)
Washington State (518)
West Virginia (3)
Wisconsin (49)
716,844 Results for "intra cellular therapies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Johnson & Johnson Makes Major Neuro Play With $14.6B Intra-Cellular Buyout
Among Intra-Cellular’s neuropsychiatric assets is Caplyta, a pill approved for schizophrenia and bipolar depression and proposed for major depressive disorder.
January 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
January 13, 2025
·
20 min read
Neuroscience
Intra-Cellular Eyes Depression Approval for Caplyta as Stock Flies Under the Radar
Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening up an additional $1 billion in sales. Still, the stock remains “cheap,” according to Jefferies analysts.
December 3, 2024
·
4 min read
·
Annalee Armstrong
Press Releases
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
February 24, 2025
·
14 min read
Press Releases
Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
Pharm Country
Intra-Cellular Therapies to Participate in Two Upcoming May 2024 Investor Conferences
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, announced that it will participate in two upcoming investor conferences.
May 8, 2024
·
1 min read
Press Releases
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
November 20, 2024
·
1 min read
Business
Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
Intra-Cellular Therapies, Inc. today announced the promotion of Michael Halstead, J.D. to the position of President.
March 19, 2024
·
2 min read
Pharm Country
Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
Intra-Cellular Therapies, Inc. highlights data presentations at the American Society of Clinical Psychopharmacology Annual Meeting being held in Miami, May 28 - 31, 2024.
May 23, 2024
·
9 min read
Drug Development
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Intra-Cellular Therapies, Inc. today announced positive topline results from Study 502 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of MDD.
June 18, 2024
·
15 min read
1 of 71,685
Next
